Oligonucleotide complexes for use as anti-viral therapeutics
US7407752B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 21, 2004 |
| Grant date | Aug 5, 2008 |
| Priority date | — |
| Expiry date | Apr 21, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3511
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The methods disclosed herein are of use for the treatment of a wide variety of diseases. In particular, the methods provide for the targeting of a transcription altering agent to a specific target site of a viral genome in order to inactivate the virus. In addition, the methods provide for a triplex-forming oligonucleotide capable of interacting with a target site in a viral genome in order to alter transcription. The methods of the present invention may be used against viral pathogens or agents of bioterrorism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.